(E)-Tetrahydro-2,2-dimethyl-5-(1-methyl-1-propenyl)furan
| Common Name: |
(E)-Tetrahydro-2,2-dimethyl-5-(1-methyl-1-propenyl)furan |
| IUPAC Name: |
5-[(E)-but-2-en-2-yl]-2,2-dimethyloxolane |
| Molecular Formula: |
C10H18O |
| SMILES: |
CC=C(C)C1CCC(O1)(C)C |
| Inchi: |
1S/C10H18O/c1-5-8(2)9-6-7-10(3,4)11-9/h5,9H,6-7H2,1-4H3/b8-5+ |
| Inchi Key: |
LPEYLSKLVYWOEQ-VMPITWQZSA-N |
| Cas No: |
7416-35-5 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
2 |
| Name |
Value |
| Molecular Weight (g/mol) |
154.25 |
| Mass (g/mol) |
154.136 |
| Molar Refractivity |
48.72 |
| Net Charge |
|
| HBD |
|
| HBA |
1 |
| Rt Bonds |
1 |
| Rings |
1 |
| TPSA |
9.23 |
| Hetero Atoms |
1 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
60.00 @ 15.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
1.137 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.80 |
| LogP |
2.91 |
| iLOGP |
2.75 |
| XLOGP3 |
2.72 |
| WLOGP |
2.91 |
| MLOGP |
2.30 |
| ESOL Log S |
-2.44 |
| ESOL Solubility (mg/ml) |
0.555 |
| ESOL Solubility (mol/l) |
0.004 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.57 |
| Ali Solubility (mg/ml) |
0.42 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.11 |
| Silicos-IT Solubility (mg/ml) |
1.19 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.31 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.839 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.305 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Warning |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
